Cord Blood America Sponsoring Golf Classic to Advance Stem Cell Research
-- Treating Stroke, Parkinson's, Alzheimer's --
LAS VEGAS, April 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it is a sponsor of the 2010 Brodie Golf Classic Charity Invitational on April 19th at La Quinta County Club, California.
"John Brodie was a well known, successful quarterback with the NFL's San Francisco 49ers, a Senior PGA golf professional and an NBC broadcaster. He suffered a massive stroke in 2000. Adult stem cell treatments have dramatically improved his ability to walk and speak again. The golf classic he sponsors contributes 100 percent of the net proceeds to the New York Stem Cell Foundation, an organization dedicated to furthering the research of Stem Cell therapies in treating stroke, Parkinson's disease, Alzheimer's and spinal cord injury. This is exactly the kind of charitable giving that Cord Blood America, as a major national and international stem cell storage company, is proud to be involved in," said Matthew Schissler, Cord Blood America co-founder and CEO.
Information about the charity classic is available at http://www.brodiegolfclassic.org, which also features an educational write-up about stem cell research. "We are pleased to be a sponsor of this event and we want to do all that we can to increase research into the numerous potential uses of stem cells to treat diseases which, up until now, have no cure and even very few effective treatments," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
About The New York Stem Cell Foundation
Founded in 2005, The New York Stem Cell Foundation is dedicated to furthering stem cell research to advance the search for cures of the major diseases of our time. NYSCF opened the first privately funded stem cell laboratory in New York City in March 2006 to serve as a "safe haven" where scientists can conduct advanced stem cell research free of federal restrictions. The organization supports scientists engaged in stem cell research through grants, fellowships and symposia; runs collaborative, state-of-the-art research facilities directly focused on curing disease; and educates the public about the importance and potential benefits of stem cell research. For more information, visit www.nyscf.org.
CONTACT: |
|
Paul Knopick |
|
E & E Communications |
|
949/707-5365 |
|
SOURCE Cord Blood America, Inc.
Share this article